Skip to main content

Graham Capital Management, L.P.

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1315421 ROWAYTON, CT

Position in AKBA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$345,209
-$261,059 QoQ
Shares Held
248,352
-34.0% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Graham Capital Management, L.P. holds $5,287,451 across 16 Drug Manufacturers - Specialty & Generic names. AKBA ranks #7 (6.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 AKBA
Akebia Therapeutics, Inc.
This page
248,352 $345,209

All Filings in AKBA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $345,209 248,352
2025-12-31 $606,268 376,564
2025-09-30 $627,834 229,976
2025-06-30 $138,898 38,159
2025-03-31 $33,701 17,553
2024-06-30 $58,776 57,624
2024-03-31 $52,678 28,786
2023-12-31 $29,304 23,633
2023-06-30 $24,326 26,586